Edwards Lifesciences (EW) Construction in Progress (2023 - 2025)

Edwards Lifesciences' Construction in Progress history runs 3 years deep, the most recent figure standing at $301.2 million for Q4 2025.

• On a quarterly basis, Construction in Progress rose 23.44% year-over-year to $301.2 million in Q4 2025; TTM through Dec 2025 was $301.2 million, a 23.44% increase from a year earlier, with the FY2025 full-year figure at $301.2 million, up 23.44% from the prior year.
• Construction in Progress grew to $301.2 million in Q4 2025 per EW's latest filing, from $244.0 million in the prior quarter.
• Across five years, Construction in Progress topped out at $301.2 million in Q4 2025 and bottomed at $244.0 million in Q4 2024.
• The 3-year median for Construction in Progress is $292.5 million (2023), against an average of $279.2 million.
• Across the five-year window, Construction in Progress declined 16.58% in 2024 and gained 23.44% in 2025, its largest moves.
• Year by year, Construction in Progress stood at $292.5 million in 2023, then retreated by 16.58% to $244.0 million in 2024, then rose by 23.44% to $301.2 million in 2025.
• Per Business Quant, the three latest EW Construction in Progress figures stand at $301.2 million (Q4 2025), $244.0 million (Q4 2024), and $292.5 million (Q4 2023).